Overexpression of CD40L was described on B and T cells in patients suffering from SLE, RA, and psoriatic arthritis [128], while the level of its expression on T cells correlated with poor outcome, disease severity, and flares [129]. This evidence concerns the gene CD40LG and rheumatoid arthritis.